{"organizations": [], "uuid": "4c7f800824bf84804f6604ad262064bbd34003a4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-nestle-declines-to-comment-on-inte/brief-nestle-declines-to-comment-on-interest-in-pfizer-merck-units-idUSFWN1Q50JV", "country": "US", "domain_rank": 408, "title": "BRIEF-Nestle declines to comment on interest in Pfizer, Merck units", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-15T11:48:00.000+02:00", "replies_count": 0, "uuid": "4c7f800824bf84804f6604ad262064bbd34003a4"}, "author": "", "url": "https://www.reuters.com/article/brief-nestle-declines-to-comment-on-inte/brief-nestle-declines-to-comment-on-interest-in-pfizer-merck-units-idUSFWN1Q50JV", "ord_in_thread": 0, "title": "BRIEF-Nestle declines to comment on interest in Pfizer, Merck units", "locations": [], "entities": {"persons": [{"name": "silke koltrowitz", "sentiment": "none"}, {"name": "merck", "sentiment": "none"}], "locations": [{"name": "u.s", "sentiment": "none"}], "organizations": [{"name": "pfizer", "sentiment": "negative"}, {"name": "merck", "sentiment": "negative"}, {"name": "nestle sa", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 15, 2018 / 9:48 AM / in 16 minutes BRIEF-Nestle declines to comment on interest in Pfizer, Merck units Reuters Staff 1 Min Read Feb 15 (Reuters) - Nestle Sa: * CEO SAYS NO COMMENT ON INTEREST IN PFIZER, MERCK CONSUMER HEALTH UNITS, BUT IS GENERALLY INTERESTED IN EXPANDING ITS CONSUMER HEALTH BUSINESS * ZONE AMERICAS HEAD SAYS EXPECTS TO SEE LIMITED PRICE INCREASES IN THE U.S. THIS YEAR, COUNTS ON VOLUME GROWTH TO DRIVE IMPROVEMENT IN ORGANIC GROWTH Further company coverage: (Reporting by Silke Koltrowitz)", "external_links": [], "published": "2018-02-15T11:48:00.000+02:00", "crawled": "2018-02-15T12:14:50.015+02:00", "highlightTitle": ""}